Recently, in a small pilot study with 10 metastatic EGFR-mutant NSCLC patients, it was shown that EVs had a better detection rate that ctDNA, and that variations in the mutant EV-RNA burden could mirror disease status [181]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.